Title: Agricultural Resource Management Phase 3 Economic Surveys.

OMB Control Number: 0535-0275.

Expiration Date of Current Approval: June 30, 2026.

Type of Request: To revise and extend a currently approved information collection for a period of three years.

Abstract: The Agricultural Resource Management Surveys (ARMS) are the primary source of information for the U.S. Department of Agriculture on a broad range of issues related to production practices, costs and returns, and contractor expenses. Data are collected at both the whole-farm level and for selected commodities.

The ARMS Phase 3 Economic Surveys are the only annual source of information available for objective evaluation of many critical issues related to agriculture and the rural economy. These include annual whole-farm financial data sufficient to estimate income by type of operation, loan commodities, operator household income, credit, farm structure and organization; as well as marketing information and other economic data related to input usage, production practices, and crop substitution possibilities.

Data from ARMS are used to produce estimates of net farm income by type of commercial producer as required in 7 U.S.C. 7998, as amended, and estimates of enterprise production costs as required in 7 U.S.C. 1441(a), as amended. ARMS data are also used to develop the Prices Paid Index, a component of the Parity Index referenced in the Agricultural Adjustment Act of 1938, as amended. These indexes are used to calculate the annual federal grazing fee rates under the Public Rangelands Improvement Act of 1978 and Executive Order 12548, and as promulgated in regulations at 36 CFR 222.51, as amended.

In addition, ARMS data support estimates of sector-wide production expenditures and other income components used by the USDA Economic Research Service (ERS) to construct national income and value-added estimates. These are transmitted to the U.S. Department of Commerce, Bureau of Economic Analysis, for use in calculating Gross Domestic Product (GDP), in accordance with a 1956 agreement between the Office of Management and Budget and the Departments of Agriculture and Commerce to publish a single set of farm income estimates.

Authority: These data will be collected under the authority of 7 U.S.C. 2204(a). Individually identifiable data collected under this authority are governed by section 1770 of the Food Security Act of 1985, 7 U.S.C. 2276, which requires USDA to afford strict confidentiality to non-aggregated data provided by respondents. This Notice is submitted in accordance with the Paperwork Reduction Act of 1995 (at 44 U.S.C. 3501, et seq. ) and Office of Management and Budget regulations at 5 CFR part 1320.

All NASS employees and NASS contractors must also fully comply with all provisions of the Confidential Information Protection and Statistical Efficiency Act (CIPSEA) of 2018, Title III of Public Law 115-435, codified in 44 U.S.C. Ch. 35. CIPSEA supports NASS's pledge of confidentiality to all respondents and facilitates the agency's efforts to reduce burden by supporting statistical activities of collaborative agencies through designation of NASS agents, subject to the limitations and penalties described in CIPSEA.

Estimate of Burden: The public reporting burden for this collection of information is estimated to average approximately 22 minutes per respondent.

Respondents: Farmers, ranchers, farm managers, farm contractors, and farm households.

Estimated Number of Respondents: Approximately 48,500 respondents will be sampled annually.

Estimated Total Annual Burden on Respondents: Approximately 71,000 hours per year.

Comments: Comments are invited on: (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on those who are to respond, through the use of appropriate automated, electronic, mechanical, technological or other forms of information technology collection methods.

All responses to this notice will become a matter of public record and be summarized in the request for OMB approval.

Title: Agricultural Resources Management Survey and Chemical Use Surveys.

OMB Control Number: 0535-0218.

Expiration Date of Current Approval: July 31, 2027.

Type of Request: To revise and extend a currently approved information collection for a period of three years.

Abstract: The Agricultural Resource Management Surveys (ARMS) are the primary source of information for the U.S. Department of Agriculture on a broad range of issues related to production practices, costs and returns, pest management, chemical usage, and contractor expenses. Data are collected at both the whole-farm level and for selected commodities.

Historically, the ARMS docket included a screening phase, a chemical use phase, and an economic phase. This notice and information collection focus on ARMS Phases 1 and 2—screening, production practices, and chemical use surveys.

Cost of Production: Congress mandates the development of annual estimates for the cost of producing wheat, feed grains, cotton, and dairy commodities. USDA also collects cost of production data for soybeans, rice, peanuts, hogs, and beef cow-calf operations to support economic comparisons among major farm commodities competing for U.S. agricultural resources.

Chemical Use Surveys: Congress has directed NASS and ERS to build nationally coordinated databases on agricultural chemical use and related farm practices. These databases are essential for producing environmental and economic estimates and help producers and researchers address on-farm environmental concerns while maintaining productivity.

Authority: These data will be collected under the authority of 7 U.S.C. 2204(a). Individually identifiable data collected under this authority are governed by section 1770 of the Food Security Act of 1985, 7 U.S.C. 2276, which requires USDA to afford strict confidentiality to non-aggregated data provided by respondents. This Notice is submitted in accordance with the Paperwork Reduction Act of 1995 (at 44 U.S.C. 3501, et seq. ) and Office of Management and Budget regulations at 5 CFR part 1320.

All NASS employees and NASS contractors must also fully comply with all provisions of the Confidential Information Protection and Statistical Efficiency Act (CIPSEA) of 2018, Title III of Public Law 115-435, codified in 44 U.S.C. Ch. 35. CIPSEA supports NASS's pledge of confidentiality to all respondents and facilitates the agency's efforts to reduce burden by supporting statistical activities of collaborative agencies through designation of NASS agents, subject to the limitations and penalties described in CIPSEA.

Estimate of Burden: The public reporting burden for this collection is estimated to average approximately 8 minutes per response.

Respondents: Farmers, ranchers, farm managers, farm contractors, and farm households.

Estimated Number of Respondents: Approximately 118,000 respondents will be sampled annually. Fewer than 20 percent will be contacted more than once per year.

Estimated Total Annual Burden on Respondents: Approximately 52,000 hours per year.

Comments: Comments are invited on: (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on those who are to respond, through the use of appropriate automated, electronic, mechanical, technological or other forms of information technology collection methods.

All responses to this notice will become a matter of public record and be summarized in the request for OMB approval.

Title: Current Agricultural Industrial Reports (CAIR).

OMB Control Number: 0535-0254.

Expiration Date of Approval: June 30, 2026.

Type of Request: To revise and extend a currently approved information collection for a period of three years.

Abstract: NASS began collecting data for the Current Agricultural Industrial Reports (CAIR) program in the latter half of 2014, replacing a portion of the Current Industrial Reports (CIR) program (0607-0476) previously conducted by the U.S. Census Bureau. The CIR program was discontinued on April 30, 2012, and included 47 different surveys.

The CAIR program produces four separate publications that provide critical data on the utilization of U.S. agricultural commodities. These include crop data on acreage, production, prices, and stocks ( e.g., grains, oilseeds, cotton, nuts), as well as livestock and poultry data on production, slaughter, prices, and cold storage volumes. CAIR data also inform how these commodities are processed into products such as fuels, cooking oils, flour, and fabric—offering a more complete picture of agriculture's role in the U.S. economy.

Primary users of the data include government agencies, regulatory bodies, trade associations, business firms, and research organizations. The USDA World Agricultural Outlook Board (WAOB), Bureau of Economic Analysis (BEA), and Bureau of Labor Statistics (BLS) use the data for GDP estimation, productivity analysis, and industrial monitoring.

NASS will use the information collected solely for statistical purposes and will publish only aggregated data.

Authority: The census of agriculture and subsequent follow-on censuses are required by law under the “Census of Agriculture Act of 1997,” 7 U.S.C. 2204(g). Individually identifiable data collected under this authority are governed by Section 1770 of the Food Security Act of 1985 as amended, 7 U.S.C. 2276, which requires USDA to afford strict confidentiality to non-aggregated data provided by respondents. This Notice is submitted in accordance with the Paperwork Reduction Act of 1995, Public Law 104-13 and Office of Management and Budget regulations at 5 CFR part 1320.

All NASS employees and NASS contractors must also fully comply with all provisions of the Confidential Information Protection and Statistical Efficiency Act (CIPSEA) of 2018, Title III of Public Law 115-435, codified in 44 U.S.C. Ch. 35. CIPSEA supports NASS's pledge of confidentiality to all respondents and facilitates the agency's efforts to reduce burden by supporting statistical activities of collaborative agencies through designation of NASS agents, subject to the limitations and penalties described in CIPSEA.

Estimate of Burden: The public reporting burden for this information collection is estimated to average between 10 and 40 minutes per response. Publicity materials and instruction sheets are expected to contribute approximately 15 minutes of burden per respondent annually. To support response rates, NASS will send email and text reminders, which are estimated to result in a total annual burden of 190 hours. For respondents who decline to complete the survey, an estimated 2 minutes of burden per contact attempt will be applied.

Respondents: Managers of processing facilities that produce oils and fats from animals, grains, oilseeds, nuts, tree fruits, or vegetables; or operations involved in storing, rendering, or marketing these products. Managers of ethanol plants, cotton gins, and flour mills are also included.

Estimated Number of Respondents: 650.

Estimated Total Annual Burden on Respondents: 2,400 hours.

Comments: Comments are invited on: (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, technological or other forms of information technology collection methods.

All responses to this notice will become a matter of public record and be summarized in the request for OMB approval.

On June 30, 2025, Commerce published in the Federal Register a notice of opportunity to request an administrative review of the CVD order on certain quartz surface products from China. 1 Commerce received a timely request for review of the CVD order from Karinastone (Malaysia) Sdn Bhd (Karinastone), an exporter of the subject merchandise. 2

On August 22, 2025, in accordance with section 751(a) of the Tariff Act of 1930, as amended (the Act) and 19 CFR 351.221(c)(1)(i), Commerce published the initiation notice in the Federal Register . 3 On September 12, 2025, we notified interested parties that information from U.S. Customs and Border Protection (CBP) indicated that there were no POR entries of the subject merchandise. 4 Further, on September 22, 2025, we notified interested parties of our intent to rescind this administrative review due to a lack of suspended entries. 5 We received no comments from interested parties regarding our intent to rescind.

Pursuant to 19 CFR 351.213(d)(3), it is Commerce's practice to rescind an administrative review of a CVD order where it concludes that there were there are no entries of subject merchandise during the POR for which liquidation is suspended. 6 Normally, upon completion of an administrative review, the suspended entries are liquidated at the CVD rates calculated for the review period. 7 Therefore, for an administrative review to be conducted, there must be a reviewable, suspended entry that Commerce can instruct CBP to liquidate at the calculated CVD rates for the review period. 8 As noted above, there were no suspended entries of subject merchandise for the company under review during the POR. Accordingly, in the absence of reviewable, suspended entries of subject merchandise during the POR, we are hereby rescinding this administrative review in its entirety, in accordance with 19 CFR 351.213(d)(3).

As Commerce has proceeded to a final rescission of this administrative review, no cash deposit rates will change. Accordingly, the current cash deposit requirements shall remain in effect until further notice.

Commerce will instruct CBP to assess countervailing duties on all appropriate entries. Countervailing duties shall be assessed at rates equal to the cash deposit rate of estimated countervailing duties required at the time of entry, or withdrawal from warehouse, for consumption, in accordance with 19 CFR 351.212(c)(1)(i). Commerce intends to issue assessment instructions to CBP no earlier than 35 days after the date of publication of this rescission notice in the Federal Register .

This notice serves as a final reminder to parties subject to administrative protective order (APO) of their responsibility concerning the return or destruction of proprietary information disclosed under APO in accordance with 19 CFR 351.305, which continues to govern business proprietary information in this segment of the proceeding. Timely written notification of the return or destruction of the APO materials or conversion to judicial protective order is hereby requested. Failure to comply with regulations and terms of an APO is a violation, which is subject to sanction.

This notice is issued and published in accordance with sections 751(a)(1) and 777(i)(l) of the Act, and 19 CFR 351.213(d)(4).

This 36(b)(1) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 24-97, Policy Justification, and Sensitivity of Technology.

(i) Prospective Purchaser: Government of Japan

(ii) Total Estimated Value:

(iii) Description and Quantity or Quantities of Articles or Services under Consideration for Purchase:

(iv) Military Department: Navy (JA-P-AVM)

(v) Prior Related Cases, if any: JA-P-AUF; JA-P-AUN; JA-P-AUU

(vi) Sales Commission, Fee, etc., Paid, Offered, or Agreed to be Paid: None known at this time

(vii) Sensitivity of Technology Contained in the Defense Article or Defense Services Proposed to be Sold: See Attached Annex

(viii) Date Report Delivered to Congress: October 18, 2024

* as defined in Section 47(6) of the Arms Export Control Act.

The Government of Japan has requested to buy up to two hundred twelve (212) Rolling Airframe Missiles (RAM) Block 2B, RIM-116E. The following non-MDE items will also be included: RAM Guided Missiles Round Pack (GMRP); Tri-Pack shipping and storage containers; training equipment; operator manuals and technical documentation; U.S. Government and contractor engineering, technical, and logistics support and assistance; support for establishment of an Intermediate Level Maintenance Facility (ILMF); and other related elements of logistics and program support. The estimated total cost is $360 million.

This proposed sale will support the foreign policy goals and national security objectives of the United States by improving the security of a major ally that is a force for political stability and economic progress in the Indo-Pacific region.

The proposed sale will improve Japan's capability to meet current and future threats by providing significantly enhanced area defense capabilities over critical East Asian and Western Pacific air and sea lines of communication. It is vital to U.S. national interests that Japan develops and maintains a strong and ready self-defense capability. Japan will have no difficulty absorbing these articles into its armed forces.

The proposed sale of this equipment and support will not alter the basic military balance in the region.

The principal contractor will be RTX Corporation, located in Tucson, AZ. There are no known offset agreements proposed in connection with this potential sale.

Implementation of this proposed sale will not require the assignment of any additional U.S. or contractor representatives to Japan.

There will be no adverse impact on U.S. defense readiness as a result of this proposed sale.

(vii) Sensitivity of Technology

1. The RIM-116E Rolling Airframe Missile (RAM) is an autonomous, lightweight, supersonic, surface-to-air tactical missile for ship self-defense against current and evolving anti-ship cruise missile threats. Advanced technology in the RIM-116E includes dual-mode (radio frequency/infrared) (RF/IR) guidance with IR all-the-way capability for non-emitting threats.

2. The highest classification of defense articles, components, and services included in this potential sale is CONFIDENTIAL.

3. If a technologically advanced adversary were to obtain knowledge of the specific hardware and software elements, the information could be used to develop countermeasures that might reduce weapon system effectiveness or be used in the development of a system with similar or advanced capabilities.

4. A determination has been made that Japan can provide substantially the same degree of protection for the sensitive technology being released as the U.S. Government. This sale is necessary in furtherance of the U.S. foreign policy and national security objectives outlined in the Policy Justification.

5. All defense articles and services listed in this transmittal have been authorized for release and export to the Government of Japan.

This 36(b)(1) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 20-79, Policy Justification, and Sensitivity of Technology.

(i) Prospective Purchaser: Government of the United Arab Emirates

(ii) Total Estimated Value:

Funding Source: National Funds

(iii) Description and Quantity or Quantities of Articles or Services under Consideration for Purchase:

(iv) Military Department: Army (AE-B-ZUZ)

(v) Prior Related Cases, if any: AE-B-ZVE

(vi) Sales Commission, Fee, etc., Paid, Offered, or Agreed to be Paid: None

(vii) Sensitivity of Technology Contained in the Defense Article or Defense Services Proposed to be Sold: See Attached Annex

(viii) Date Report Delivered to Congress: October 11, 2024

* as defined in Section 47(6) of the Arms Export Control Act.

The Government of the United Arab Emirates has requested to buy two hundred fifty-nine (259) Guided Multiple Launch Rocket System (GMLRS) M31A1 Unitary Pods (1,554 missiles at six missiles per pod) and two hundred three (203) Army Tactical Missile Systems (ATACMS) M57 Unitary Missiles. Also included are publications; personnel training and training equipment; software development; U.S. Government and contractor engineering, technical and logistics support services; and other related elements of logistical and program support. The estimated total cost is $1.2 billion.

The proposed sale will support the foreign policy and national security objectives of the U.S. by helping to improve the security of an important regional partner. The United Arab Emirates has been, and continues to be, a vital U.S. partner for political stability and economic progress in the Middle East.

The proposed sale will improve the United Arab Emirates' capability to meet current and future threats by modernizing its armed forces. This sale will contribute to the United Arab Emirates' military goals of updating capability while further enhancing interoperability with the U.S. and other partners. The United Arab Emirates will have no difficulty absorbing these articles into its armed forces.

The proposed sale of this equipment and support will not alter the basic military balance in the region.

The principal contractor will be Lockheed Martin, Grand Prairie, TX. There are no known offset agreements proposed in connection with this potential sale.

Implementation of this proposed sale will require the temporary assignment of four (4) U.S. Government and four (4) U.S. contractor representatives to the United Arab Emirates for a duration of no longer than ten (10) days to support new software equipment training and the stockpile reliability program.

There will be no adverse impact on U.S. defense readiness as a result of this proposed sale.

(vii) Sensitivity of Technology:

1. The Guided Multiple Launch Rocket System (GMLRS) is a solid propellant artillery rocket for the High Mobility Artillery Rocket System (HIMARS). GMLRS uses GPS-aided inertial guidance to accurately and quickly deliver a single high-explosive blast fragmentation warhead to targets. The GMLRS has an operational range of 15-70km.

2. The M57 Army Tactical Missile Systems (ATACMS) is a conventional, semi-ballistic missile for the High Mobility Artillery Rocket System (HIMARS). ATACMS is a guided by GPS-aided inertial navigation systems to provide precise targeting over ranges of up to 300km.

3. The highest level of classification of defense articles, components, and services included in this potential sale is SECRET.

4. If a technologically advanced adversary were to obtain knowledge of the specific hardware and software elements, the information could be used to develop countermeasures that might reduce weapon system effectiveness or be used in the development of a system with similar or advanced capabilities.

5. A determination has been made that the United Arab Emirates can provide substantially the same degree of protection for the sensitive technology being released as the U.S. Government. This sale is necessary in furtherance of the U.S. foreign policy and national security objectives outlined in the Policy Justification.

6. All defense articles and services listed in this transmittal have authorized for release and export to the Government of the United Arab Emirates.

This 36(b)(5)(C) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 24-0W.

(i) Prospective Purchaser: Government of Denmark

(ii) Sec. 36(b)(1), AECA Transmittal No.: 19-44

Date: August 27, 2019

Implementing Agency: Navy

(iii) Description: On August 27, 2019, Congress was notified by congressional certification transmittal number 19-44 of the possible sale, under Section 36(b)(1) of the AECA, of up to nine (9) AN/AQS-22 Airborne Low Frequency Sonar (ALFS) Systems. Also included were six hundred (600) AN/SSQ-36/53/62 Sonobuoys; spare and repair parts; support and test equipment; communication equipment; publications and technical documentation; personnel training and training equipment; United States (U.S.) Government and contractor engineering, technical, and logistics support services; and other related elements of logistical and program support. The total estimated value was $200 million. Major Defense Equipment (MDE) constituted $100 million of this total.

On November 20, 2019, Congress was notified by congressional certification transmittal number 1J-19, under Section 36(b)(5)(A) of the Arms Export Control Act, of the addition of the following MDE: 1) twenty (20) MK 54 All Up Round Lightweight Torpedoes; and 2) two (2) MK 54 Exercise Torpedoes (EXTORPS) (MK 54 Kit Procurement Required). Also included were MK 54 LWT Spares; torpedo containers; Recoverable Exercise Torpedoes (REXTORP) with containers; Fleet Exercise Section (FES) and fuel tanks; air launch accessories for fixed wing; torpedo spare parts, training, publications, support, and test equipment; U.S. Government and contractor engineering, technical, and logistics support services; and other related elements of logistics and program support. The addition of these items resulted in a net increase in MDE cost of $19 million, resulting in a revised MDE cost of $119 million. The total estimated case value increased to $240 million.

This transmittal notifies the inclusion of the following additional MDE items: twelve (12) MK 54 MOD 0 Lightweight Torpedo all up rounds. The following non-MDE items will also be included: torpedo containers; Recoverable Exercise Torpedoes (REXTORP); Fleet Exercise Sections (FES) and fuel tanks; U.S. Government and contractor engineering, technical, and logistics support services; and other related elements of logistics and program support. The estimated total value of the new MDE items is $40 million, resulting in a revised estimated MDE value of $159 million. The estimated total value of the new non-MDE items is $15 million, resulting in a revised non-MDE value of $136 million. The estimated total case value will increase by $55 million to $295 million.

(iv) Significance: This notification is being provided because the additional items were not enumerated in the original notification. The proposed sale will improve Denmark's capability to meet current and future threats.

(v) Justification: This proposed sale will support the foreign policy goals and national security objectives of the U.S. by improving the security of a NATO Ally that is a force for political stability and economic progress in Europe.

(vi) Sensitivity of Technology:

The MK 54 Lightweight Torpedo is a conventional torpedo that can be launched from surface ships, rotary and fixed wing aircrafts. The MK 54 LWT is an upgrade to the MK 46 Torpedo that entails replacement of the torpedo's sonar and guidance and control systems with modem technology. The new guidance and control system uses a mixture of commercial-off-the-shelf and custom-built electronics. The warhead, fuel tank, and propulsion system from the MK 46 torpedo are re-used in the MK 54 torpedo configuration with minor modifications.

The highest level of classification of defense articles, components, and services included in this potential sale is SECRET.

(vii) Date Report Delivered to Congress: October 21, 2024

This 36(b)(1) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 20-62, Policy Justification, and Sensitivity of Technology.

(i) Prospective Purchaser: Kingdom of Saudi Arabia

(ii) Total Estimated Value:

Funding Source: National Funds

(iii) Description and Quantity or Quantities of Articles or Services under Consideration for Purchase:

(iv) Military Department: Army (SR-B-WCZ)

(v) Prior Related Cases, if any: SR-B-WAL

(vi) Sales Commission, Fee, etc., Paid, Offered, or Agreed to be Paid: None

(vii) Sensitivity of Technology Contained in the Defense Article or Defense Services Proposed to be Sold: See Attached Annex

(viii) Date Report Delivered to Congress: October 11, 2024

* as defined in Section 47(6) of the Arms Export Control Act.

The Kingdom of Saudi Arabia has requested to buy Two Thousand Five Hundred Three (2,503) AGM-114R3 Hellfire II missiles (3 for lot acceptance testing). Also included are support and test equipment; integration and test support; spare and repair parts; software delivery and support; publications and technical documentation; personnel training and training equipment; U.S. Government and contractor engineering, technical and logistics support services; storage; and other related elements of logistical and program support. The total estimated cost is $655 million.

This proposed sale will support the foreign policy and national security of the U.S. by helping to improve the security of a friendly country that continues to be an important force for political and economic progress in the Middle East.

The proposed sale will improve Saudi Arabia's capability to meet current and future threats and improve interoperability with systems operated by U.S. Forces and other Gulf countries. Saudi Arabia's continued investment in its defensive capabilities is crucial to protecting its borders, energy infrastructure, and its residents. Saudi Arabia will have no difficulty absorbing these missiles into its armed forces.

The proposed sale of this equipment and support will not alter the basic military balance in the region.

The principal contractor will be The Lockheed Martin Corporation, Troy, AL. The purchaser typically requests offsets. Any offset agreement will be defined in negotiations between the purchaser and the contractor.

Implementation of this proposed sale will not require the assignment of any additional U.S. Government or contractor representatives to Saudi Arabia. The only additional U.S. military support required would be Technical Assistance Field Team (TAFT) visits during training phases.

There will be no adverse impact on U.S. defense readiness as a result of this proposed sale.

(vii) Sensitivity of Technology:

1. The AGM-114R3 Hellfire II missile is a precision strike, Semi-Active Laser (SAL)-guided missile and is the principal air-to-ground weapon for the Army. The AGM-114R3 Hellfire II missile provides the warfighter with an air-to-ground, point-target precision strike capability to defeat advanced armor and an array of traditional and nontraditional targets.

2. The highest level of classification of defense articles, components, and services included in this potential sale is SECRET.

3. If a technologically advanced adversary were to obtain knowledge of the hardware and software elements, the information could be used to develop countermeasures or equivalent systems which might reduce system effectiveness or be used in the development of a system with similar or advanced capabilities.

4. A determination has been made that the Government of Saudi Arabia can provide substantially the same degree of protection for the sensitive technology being released as the U.S. Government. This sale is necessary in furtherance of the U.S. foreign policy and national security objectives outlined in the Policy Justification.

5. All defense articles and services listed in this transmittal are authorized for release and export to the Kingdom of Saudi Arabia.

This 36(b)(1) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 21-15, Policy Justification, and Sensitivity of Technology.

(i) Prospective Purchaser: Kingdom of Saudi Arabia

(ii) Total Estimated Value:

Funding Source: National Funds

(iii) Description and Quantity or Quantities of Articles or Services under Consideration for Purchase:

(iv) Military Department: Army (SR-B-UDA, SR-B-UDC)

(v) Prior Related Cases, if any: None

(vi) Sales Commission, Fee, etc., Paid, Offered, or Agreed to be Paid: None

(vii) Sensitivity of Technology Contained in the Defense Article or Defense Services Proposed to be Sold: See Attached Annex

(viii) Date Report Delivered to Congress: October 11, 2024

* as defined in Section 47(6) of the Arms Export Control Act.

The Kingdom of Saudi Arabia has requested to buy ten thousand (10,000) M456 series, 105mm, High Explosive Anti-Tank Tracer cartridges. Also included are various types of tank, howitzer, and machine gun ammunition; propelling charges; fuzes; primers; grenades; support and test equipment; integration and test support; spare and repair parts; software delivery and support; publications and technical documentation; personnel training and training equipment; U.S. Government and contractor engineering, technical and logistics support services; storage; and other related elements of logistical and program support. The total estimated cost is $139 million.

This proposed sale will support U.S. foreign policy and national security objectives by helping to improve the security of a friendly country that continues to be an important force for political stability and economic growth in the Middle East.

The proposed sale will improve Saudi Arabia's capability to meet current and future threats and improve interoperability with systems operated by U.S. Forces and other Gulf countries. Saudi Arabia's continued investment in its defense capabilities is crucial to protecting its borders, energy infrastructure, and its residents. Saudi Arabia will have no difficulty absorbing these munitions into its armed forces.

The proposed sale of this equipment and support will not alter the basic military balance in the region.

This ammunition will come from a combination of U.S. Army stock and new procurement. The procurement vendors are unknown at this time. The purchaser typically requests offsets. Any offset agreement will be defined in negotiations between the purchaser and the contractor.

Implementation of this proposed sale will not require the assignment of any additional U.S. Government or contractor representatives to Saudi Arabia.

There will be no adverse impact on U.S. defense readiness as a result of this proposed sale.

(vii) Sensitivity of Technology:

1. The 105mm M456A2 High Explosive, Antitank Multipurpose, with Tracer, Cartridge (DODIC C508) is designed for use against armored targets and contains Composition B Explosive (an explosive consisting of castable mixtures of RDX and TNT) and a copper shaped charge liner inside a steel body. Saudi Arabia will use them in their M60A3 tanks.

2. The 155mm M795 High Explosive Projectile (DODIC D529), will be used in Saudi Arabia's M109 series howitzers. This item is employed against personnel; trucks; electronic surveillance and target acquisition devices; supply points; command and control and communications (C3) installations; and mechanized and armored forces.

3. The 155mm M231 Propelling Charge (DODIC DA12) will be used in Saudi Arabia's M109 series howitzers. The Modular Artillery Charge System (MACS) consists of two propelling charge module types, the M231 and the M232/M232A1, and their associated packaging. The system is compatible with all current and planned 155mm field artillery weapons.

4. The 155mm M232A1 Propelling Charge (DODIC DA13), will be used in Saudi Arabia's M109 series howitzers. The Modular Artillery Charge System (MACS) consists of two propelling charge module types, the M231 and the M232/M232A1, and their associated packaging. The system is compatible with all current and planned 155mm field artillery weapons.

5. The .50 Cal M8 Armor Piercing Incendiary/M20 Armor Piercing Incendiary-Tracer, linked 4/1 (DODIC A576), is machine gun ammunition. The cartridges contain a manganese molybdenum steel core, a point filler of incendiary composition, and a lead-antimony base seal. This configuration combines the functions of an armor piercing bullet and an incendiary bullet, and is used against flammable targets and light-armored or unarmored targets, concrete shelters, and similar bullet-resisting targets. The addition of a tracer in the M20 enables the shooter to follow the projectile trajectory to make aiming corrections.

6. The M67 Fragmentation Hand Grenade (DODIC G881) is an anti-personnel munition used to supplement small arms fire against enemies in close combat.

7. The M739A1 Artillery Point Detonating/Delay Fuze (DODIC N340) will be used in Saudi Arabia's M109 series howitzers. This item is the U.S. Army's preferred, primary fuze for 105mm and 155mm projectiles to address point detonating/delay artillery functions.

8. The M82 Percussion Primer (DODIC N523) will be used in Saudi Arabia's M109 series howitzers.

9. The 120MM Insensitive Munitions High Explosive—Tracer Non-US Inventory will be used in the M1A2 tanks. Insensitive munitions are munitions that are designed to withstand stimuli representative of severe but credible accidents. The current range of stimuli are shock, heat and adjacent detonating munitions.

10. The highest level of classification of defense articles, components, and services included in this potential sale is UNCLASSIFIED.

11. If a technologically advanced adversary were to obtain knowledge of the hardware and software elements, the information could be used to develop countermeasures or equivalent systems which might reduce system effectiveness or be used in the development of a system with similar or advanced capabilities.

12. A determination has been made that the Government of Saudi Arabia can provide substantially the same degree of protection for the sensitive technology being released as the U.S. Government. This sale is necessary in furtherance of the U.S. foreign policy and national security objectives outlined in the Policy Justification.

13. All defense articles and services listed in this transmittal are authorized for release and export to the Kingdom of Saudi Arabia.

This 36(b)(5)(C) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 24-0A.

(i) Prospective Purchaser: Kingdom of Saudi Arabia

(ii) Sec. 36(B)(1), AECA Transmittal No.: 15-17

Date: May 20, 2015

Implementing Agency: Navy

Funding Source: National Funds

(iii) Description: On May 20, 2015, Congress was notified by congressional certification transmittal number 15-17 of the possible sale, under Section 36(b)(l) of the Arms Export Control Act, of ten (10) MH-60R multi-mission helicopters with fourteen (14) APS-153(V) Multi-Mode radars (10 installed, 2 spares and 2 for testing); twenty-four T-700 GE 401 C engines (20 installed and 4 spares); twelve (12) APX-123 Identification Friend or Foe transponders (10 installed and 2 spares); fourteen (14) AN/AAS-44C(V) Multi-Spectral Targeting Systems Forward Looking Infrared Radars (10 installed, 2 spares, and 2 for testing); twenty-six (26) Embedded Global Positioning System/Inertial Navigation Systems with Selective Availability/Anti-Spoofing Module (20 installed and 6 spares); Link-16 capability; one-thousand (1,000) AN/SSQ-36/53/62 Sonobuoys; thirty-eight (38) AGM-114R Hellfire II missiles; five (5) AGM-114 M36-E9 Captive Air Training missiles; four (4) AGM-114Q Hellfire Training Missiles; three-hundred eighty (380) Advanced Precision Kill Weapons Systems rockets; twelve (12) M-240D crew served weapons; and twelve (12) GAU-21 crew served weapons. Also included were spare engine containers, facilities study and design; spare and repair parts; support and test equipment; communication equipment; aerial refueling services; ferry support; publications and technical documentation; personnel training and training equipment; United States (U.S.) Government and contractor engineering, technical and logistics support services; and other elements of logistical and program support. The estimated cost was $1.90 billion. Major Defense Equipment (MDE) constituted $1.25 billion of this total.

On September 15, 2015, Congress was notified by congressional certification transmittal number 0J-15 of the inclusion of two (2) AN/AQS-22 Airborne Low Frequency Sonar (ALFS). The AN/AQS-22 was declared Major Defense Equipment (MDE) in early June 2015, after transmittal number 15-17 was notified to Congress. Prior to this determination, the units were included in the value of the original transmittal but not enumerated or valued as MDE. Upgrading the status of this equipment to MDE resulted in an increase in MDE of $9 million, but the total case value remained at $1.90 billion.

On May 24, 2019, Congress was notified by congressional certification transmittal number 0O-19 of the inclusion of ten (10) Link 16 Multifunctional Information Distribution System—Low Volume Terminals (MIDS-LVT) Block Upgrade Two terminals to be installed on Saudi Arabia's MH-60R Helicopters; twenty-four (24) spare Link 16 MIDS-LVT Block Upgrade Two terminals; support equipment; engineering and technical support, training, and other related elements of program support. The total MDE value was $10.9 million. The revised MDE total value was $1.269 billion. The total value remained $1.90 billion.

This transmittal notifies inclusion of the following additional MDE items: six hundred eighty-two (682) Advanced Precision Kill Weapons System (APKWS) rockets; one hundred fifty-three (153) AGM-114R Hellfire II missiles; and one (1) M240D 7.62mm machine gun. The following non-MDE items will also be included: engineering and technical support; training; and other related elements of program support. The estimated total value of the new items is $71 million. This will result in a net increase in MDE value of $71 million, and a revised total MDE value of $1.34 billion. The estimated total case value will remain $1.90 billion.

(iv) Significance: This notification is being provided as the additional MDE items were not enumerated in the original notification. The proposed articles and services will support the Kingdom of Saudi Arabia by improving security in the Arabian Gulf, interoperability with U.S. forces, and the ease in conducting coordinated operations.

(v) Justification: This proposed sale will support the foreign policy goals and national security objectives of the U.S. by improving the security of a partner country that is a force for political stability and economic progress in the Gulf Region.

(vi) Sensitivity of Technology:

The Sensitivity of Technology Statement contained in the original notification applies to items reported here.

The highest level of classification of defense articles, components, and services included in this potential sale is SECRET.

(vii) Date Report Delivered to Congress: October 11, 2024

This 36(b)(1) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 24-46, Policy Justification, and Sensitivity of Technology.

(i) Prospective Purchaser: Kingdom of Saudi Arabia

(ii) Total Estimated Value:

Funding Source: National Funds

(iii) Description and Quantity or Quantities of Articles or Services under Consideration for Purchase:

(iv) Military Department: Navy (SR-P-ACD)

(v) Prior Related Cases, if any: None

(vi) Sales Commission, Fee, etc., Paid, Offered, or Agreed to be Paid: None known at this time

(vii) Sensitivity of Technology Contained in the Defense Article or Defense Services Proposed to be Sold: See Attached Annex

(viii) Date Report Delivered to Congress: October 11, 2024

* as defined in Section 47(6) of the Arms Export Control Act.

The Kingdom of Saudi Arabia has requested to buy two-hundred twenty (220) AIM-9X Block II Sidewinder Tactical Missiles. Also included are missile containers; support equipment; spares; missile software; training; and U.S. Government and contractor technical assistance; and other related elements of logistics and program support. The estimated total cost is $251.8 million.

This proposed sale will contribute to the foreign policy and national security objectives of the U.S. by ensuring the readiness of a friendly country that continues to be an important force for political stability and economic growth in the Middle East.

The proposed sale will improve the Kingdom of Saudi Arabia's capability to meet current and future threats, provide increased air defense capabilities, and support conducting self-defense and regional security missions in the Middle East. Saudi Arabia will have no difficulty absorbing this equipment into its armed forces.

The proposed sale of this equipment and support will not alter the basic military balance in the region.

The principal contractor will be RTX Corporation, located in Arlington, VA. There are no known offset agreements proposed in connection with this potential sale.

Implementation of this proposed sale will require the assignment of three U.S. Government and two to four contractor representatives annually to Saudi Arabia for a period of one week. However, ad hoc travel may be required for engineering and other support.

There will be no adverse impact on U.S. defense readiness as a result of this proposed sale.

(vii) Sensitivity of Technology:

1. The AIM-9X Block II Sidewinder Missile represents a substantial increase in performance over the AIM-9M and replaces the AIM-9X Block I Missile configuration. The missile includes a high off-boresight seeker, enhanced countermeasure rejection capability, low drag and high angle of attack airframe, and the ability to integrate the Helmet Mounted Cueing System. The most current AIM-9X Block II Operational Flight Software developed for all International Partner countries, which is authorized by U.S. Government export policy, provides fifth-generation infrared missile capabilities such as Lock-On-After-Launch, Weapons Data Link, Surface Attack, and Surface Launch. No software source code or algorithms will be released.

2. The highest level of classification of defense articles, components and services included in this potential sale is SECRET.

3. If a technologically advanced adversary were to obtain knowledge of the specific hardware and software elements, the information could be used to develop countermeasures that might reduce weapon system effectiveness or be used in the development of a system with similar or advanced capabilities.

4. A determination has been made that the Kingdom of Saudi Arabia can provide substantially the same degree of protection for the sensitive technology being released as the U.S. Government. This sale is necessary in furtherance of the U.S. foreign policy and national security objectives outlined in the Policy Justification.

5. All defense articles and services listed in this transmittal have been authorized for release and export to the Kingdom of Saudi Arabia.

This 36(b)(1) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 24-109, Policy Justification, and Sensitivity of Technology.

(i) Prospective Purchaser: Government of Romania

(ii) Total Estimated Value:

Funding Source: National Funds and Foreign Military Financing (including Ukraine Supplemental Appropriations Act funding (USAA))

(iii) Description and Quantity or Quantities of Articles or Services under Consideration for Purchase:

(iv) Military Department: Army (RO-B-UGX)

(v) Prior Related Cases, if any: None

(vi) Sales Commission, Fee, etc., Paid, Offered, or Agreed to be Paid: None known at this time

(vii) Sensitivity of Technology Contained in the Defense Article or Defense Services Proposed to be Sold: See Attached Annex

(viii) Date Report Delivered to Congress: October 7, 2024

* as defined in Section 47(6) of the Arms Export Control Act.

The Government of Romania has requested to buy four (4) AN/MPQ-64 F1 Sentinel radar systems. The following non-MDE items will also be included: IPS-250X High Assurance Internet Protocol Encryptors (HAIPE); KIV-77 Identification Friend-or-Foe (IFF) crypto appliqué with Mode 5 and Mode S capability; AN/PSN-13 Defense Advanced Global Positioning System (GPS) Receivers (DAGR) with Selective Availability Anti-Spoofing Module (SAASM); AN/PYQ-10 Simple Key Loaders (SKL); support equipment; spare and repair parts, consumables, accessories and repair and return support; classified software; classified command and control (C2) systems and communications and data supply systems; prime movers; new equipment training; weapon system support and test equipment; publications and technical documentation; personnel training and training equipment; classified software; classified books and publications; U.S. Government and contractor engineering, technical, and logistics support services; and other related elements of logistics and program support. The estimated total cost is $110 million.

This proposed sale will support the foreign policy goals and national security objectives of the United States by improving the security of a NATO Ally that is a force for political stability and economic progress in Europe.

The proposed sale will improve Romania's capability to meet current and future threats by providing a credible force that is capable of deterring adversaries and participating in NATO operations. Romania will have no difficulty absorbing this equipment into its armed forces.

The proposed sale of this equipment and support will not alter the basic military balance in the region.

The principal contractor will be RTX Corporation, located in Andover, MA. There are no known offset agreements in connection with this potential sale.

Implementation of this proposed sale will require approximately five U.S. Government and five U.S. contractor representatives to travel to Romania for a duration of up to five years to support equipment fielding and training.

There will be no adverse impact on U.S. defense readiness as a result of this proposed sale.

(vii) Sensitivity of Technology:

1. The AN/MPQ-64F1 Sentinel radar's detection range, mobility and 360-degree azimuth coverage allow it to support short or medium range air defense weapons located throughout the battle area. Sentinel acquires, tracks, and reports cruise missiles, unmanned aerial systems, and fixed and rotary wing aircraft in environments with electronic countermeasures or other complex challenges. The Sentinel F1 radar provides track data and status messages to and receives commands from the Fire Distribution Center (FDC) over the Remote Radar Data Link (RRDL). The Data Link Terminal provides the hardware connection between the radar's output panel and the FDC communication media.

2. The Sentinel radar also supports target identification by means of an integrated Identification Friend-or-Foe (IFF) system. The IFF system interrogates targets and threats automatically or as directed by the operator, and the results are automatically correlated within the radar. The radar contains operational software with specific electronic counter-countermeasures capability designed to counter electronic attack.

3. The highest level of classification of defense articles, components, and services included in this potential sale is SECRET.

4. If a technologically advanced adversary were to obtain knowledge of the specific hardware and software elements, the information could be used to develop countermeasures that might reduce weapon system effectiveness or be used in the development of a system with similar or advanced capabilities.

5. A determination has been made that Romania can provide substantially the same degree of protection for the sensitive technology being released as the U.S. Government. This proposed sale is necessary in furtherance of the U.S. foreign policy and national security objectives outlined in the Policy Justification.

6. All defense articles and services listed in this transmittal have been authorized for release and export to the Government of Romania.

This 36(b)(1) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 24-82, Policy Justification, and Sensitivity of Technology.

(i) Prospective Purchaser: Government of the Netherlands

(ii) Total Estimated Value:

(iii) Description and Quantity or Quantities of Articles or Services under Consideration for Purchase:

(iv) Military Department: Army (NE-B-YBW)

(v) Prior Related Cases, if any: None

(vi) Sales Commission, Fee, etc., Paid, Offered, or Agreed to be Paid: None

(vii) Sensitivity of Technology Contained in the Defense Article or Defense Services Proposed to be Sold: See Attached Annex

(viii) Date Report Delivered to Congress: October 16, 2024

* as defined in Section 47(6) of the Arms Export Control Act.

The Government of the Netherlands has requested to buy the following non-Major Defense Equipment items: AN/PRC-117G radios; AN/PRC-152A radios; AN/PRC-160 radios; AN/PRC-163 radios; AN/PRC-167 radios; tactical key loaders; network encryptors; Government and contractor technical assistance; spares; and other related elements of logistics and program support. The estimated total cost is $1.42 billion.

This proposed sale will support the foreign policy goals and national security objectives of the United States (U.S.) by improving the security of a NATO Ally that is a force for political stability and economic progress in Europe.

The proposed sale will improve the Netherlands' military, secure communications to improve interoperability with other NATO military forces and meet current and future enemy threats. The Netherlands will use the enhanced capability to strengthen its homeland defense, deter regional threats, and provide direct support to coalition and security cooperation efforts. The Netherlands will have no difficulty absorbing this equipment into its armed forces.

The proposed sale of this equipment and support will not alter the basic military balance in the region.

The principal contractor will be L3Harris Global Communications, Inc., located in Rochester, NY. The purchaser typically requests offsets. Any offset agreement will be defined in negotiations between the purchaser and the principal contractor. Products and services of TrellisWare Technologies, Inc., located in San Diego, CA, and ViaSat, Inc., located in Carlsbad, CA are included in the Foreign Military Sale.

Implementation of this proposed sale will not require the assignment of any additional U.S. Government representatives to the Netherlands.

There will be no adverse impact on U.S. defense readiness as a result of this proposed sale.

(vii) Sensitivity of Technology:

1. The AN/PRC-117G radios, AN/PRC-152A radios, AN/PRC-160 radios, AN/PRC-163 radios, AN/PRC-167 radios, and radio accessories are used to transmit and receive voice and data information using Type-1 encryption.

2. The highest level of classification of defense articles, components, and services included in this potential sale is UNCLASSIFIED.

3. If a technologically advanced adversary were to obtain knowledge of the specific hardware and software elements, the information could be used to develop countermeasures that might reduce weapon system effectiveness or be used in the development of a system with similar or advanced capabilities.

4. A determination has been made that the Government of the Netherlands can provide substantially the same degree of protection for the sensitive technology being released as the U.S. Government. This sale is necessary in furtherance of the U.S. foreign policy and national security objectives outlined in the Policy Justification.

5. All defense articles and services listed in this transmittal have been authorized for release and export to the Government of the Netherlands.

This 36(b)(5)(C) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104-164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 24-0G.

(i) Prospective Purchaser: Kingdom of Saudi Arabia

(ii) Sec. 36(B)(1), AECA Transmittal No.: 15-68

Date: October 19, 2015

Implementing Agency: Navy

Funding Source: National Funds

(iii) Description: On October 19, 2015, Congress was notified by congressional certification transmittal number 15-68 of the possible sale, under Section 36(b)(l) of the Arms Export Control Act, of a comprehensive naval modernization program referred to as the Saudi Naval Expansion Program II (SNEP- II). This 2015 notification of the next phase of that program will include Multi-Mission Surface Combatant (MMSC) ships and program office support. The MMSC will consist of the following Major Defense Equipment (MDE): four (4) MMSC ships (a derivative of the Freedom Variant of the U.S. Navy Littoral Combat Ship (LCS) Class) that incorporate five (5) COMBATSS-21 Combat Management Systems (four (4) installed, one (1) spare) with five (5) TRS-4D Radars (four (4) installed, one (1) spare); five (5) Identification Friend or Foe (IFF) (Mode 4- and Mode 5-capable) UPX-29 (four (4) installed, one (1) spare); five (5) Compact Low Frequency Active Passive Variable Depth Sonar (four (4) installed, one (1) spare); eight (8) MK-41 Vertical Launch Systems (VLS) (two (2) eight-cell assemblies per ship for 16 cells per hull); five-hundred thirty-two (532) tactical RIM-162 Evolved Sea Sparrow Missiles (ESSM) (one hundred twenty-eight (128) installed, twenty (20) test and training rounds, three hundred eighty-four (384) spares); five (5) AN/SWG-l (V) Harpoon Ship Command Launch Control Systems (four (4) installed (one (1) per ship), one (1) spare); eight (8) Harpoon Shipboard Launchers (two (2) installed four-tube assemblies per ship); forty-eight (48) RGM-84 Harpoon Block II Missiles (thirty-two (32) installed, sixteen (16) test and training rounds); five (5) MK-15 Mod 31 SeaRAM Close-In Weapon System (CIWS) (four (4) installed, one (1) spare); one-hundred eighty-eight (188) RIM 116C Block II Rolling Airframe Missiles (RAM) (forty-four (44) installed, twelve (12) test and training rounds, one hundred thirty-two (132) spares); five (5) MK-75 76mm OTO Melara Gun Systems (four (4) installed, one (1) spare); and forty-eight (48) 50-caliber machine guns (forty (40) installed (ten (10) per ship), eight (8) spares); ordnance; and Selective Availability Anti-Spoofing Module (SAASM) Global Positioning System/Precise Positioning Service (GPS/PPS) navigation equipment. Also included in this sale in support of the MMSC are: study, design and construction of operations; support and training facilities; spare and repair parts; support and test equipment; communications equipment employing Link 16 equipment; Fire Control System/Ceros 200 Sensor and Illuminator; 20mm Narwhal Gun; Nixie AN/SLQ-25A Surface Ship Torpedo Defense System; MK-32 Surface Vessel Torpedo Tubes; WBR-2000 Electronic Support Measure and Threat Warning System; Automatic Launch of Expendables (ALEX) Chaff and Decoy-Launching System; ARC-210 Radios; Combined Enterprise Regional Information Exchange System (CENTRIXS); Automated Digital Network System; publications and technical documentation; personnel training and training equipment; U.S. Government and contractor engineering, technical and logistics support services; and other related elements of logistical and program support. In addition, this case provided overarching program office support for the SNEP II to include: U.S. Government and contractor engineering, technical and logistics support, and other related elements of program support to meet necessities for program execution. The estimated cost was $11.25 billion. Major Defense Equipment (MDE) constituted $4.30 billion of this total.

On May 24, 2019, Congress was notified by congressional certification transmittal number 0P-19 of the inclusion of four (4) Multifunctional Information Distribution System Joint Tactical Radio Systems (MIDS JTRS) to be installed on Saudi Arabia's Multi-Mission Surface Combatant (MMSC) ships, support equipment, engineering and technical support, training, and other related elements of program support. The estimated total value remained at $11.25 billion. The total MDE value increased by $7 million to a revised MDE total of $4.307 billion.

This transmittal notifies the inclusion of one hundred forty-eight (148) RGM-114-L Longbow Hellfire missiles (32 for each of 4 ships, 20 for testing); five (5) Indra Rigel Electronic Attack Systems (1 per ship, 1 for training); and sixteen (16) M240B machine guns (4 per ship) for installation on the Kingdom of Saudi Arabia's Multi-Mission Surface Combatant (MMSC) ships. Also included is engineering and technical support; training; and other related elements of logistics and program support. The estimated total case value will remain $11.25 billion. The total MDE value will increase by $403 million to a revised $4.71 billion.

(iv) Significance: This notification is being provided as the additional MDE items were not enumerated in the original notification. The proposed sale will support the Kingdom of Saudi Arabia with added protection in the Persian Gulf to meet current and future maritime threats. The Kingdom of Saudi Arabia intends to use the capability to support interoperability with U.S. forces and to support joint and coalition warfighting capabilities in the region.

(v) Justification: This proposed sale will contribute to the foreign policy and national security objectives of the United States by ensuring the readiness of a friendly country that continues to be an important force for political stability and economic growth in the Middle East.

(vi) Sensitivity of Technology:

Longbow Hellfire (LBHF) is a short-range, precision strike, air-to-surface missile that uses millimeter wave (MMW) radar guidance. LBHF was developed as an anti-armor weapon for helicopters. As part of the U.S. Navy's Littoral Combat Ship (LCS) program, the missile was modified to serve in a shipboard surface-to-surface role. This modified missile was adapted for use in a quad pack canister installed into the Mk-41 Vertical Launch System (VLS) for the Multi-Mission Surface Combatant (MMSC) ships.

The Indra Electronic Warfare (EW) suite will provide electronic surveillance, electronic protection, and electronic attack capabilities for the MMSC ships. The EW suite that will be installed on the MMSC ships is comprised of radar electronic support measures, which detect and identify enemy communications, and active radar electronic countermeasures, which jam and disrupt enemy radar performance and communications. The Indra EW suite will not be integrated with the ship's combat management system, will not exchange classified data, and the U.S. Navy will not provide threat library information. The EW suite is available internationally through Indra.

The M240B machine guns will provide shipboard self-defense for MMSC ships in the Arabian Gulf, helping to protect critical ports and waterways while ensuring freedom of navigation.

The Sensitivity of Technology Statement contained in the original notification applies to additional items reported here.

The highest level of classification of defense articles, components, and services included in this potential sale is SECRET.

(vii) Date Report Delivered to Congress: October 11, 2024

The Department is especially interested in public comment addressing the following issues: (1) is this collection necessary to the proper functions of the Department; (2) will this information be processed and used in a timely manner; (3) is the estimate of burden accurate; (4) how might the Department enhance the quality, utility, and clarity of the information to be collected; and (5) how might the Department minimize the burden of this collection on the respondents, including through the use of information technology. Please note that written comments received in response to this notice will be considered public records.

Title of Collection: Request for Designation as an Eligible Institution Under Section 312 of the HEA and Waivers of the Non-Federal Cost Share Reimbursement.

OMB Control Number: 1840-0103.

Type of Review: Extension without change to a currently approved ICR.

Respondents/Affected Public: Private Sector; State, Local, and Tribal Governments.

Total Estimated Number of Annual Responses: 700.

Total Estimated Number of Annual Burden Hours: 4,900.

Abstract: This collection of information is necessary in order for the Secretary of Education to designate an institution of higher education eligible to apply for funding under Section 312 of the Higher Education Act of 1965, as amended. An institution must apply to the Secretary to be designated as an eligible institution.

This collection of information is gathered electronically by the Department for the purpose of determining an institution's eligibility to participate in grant programs under Section 312 of the Higher Education Act of 1965 based on its enrollment of needy students and low average Core Expenses per full-time equivalent student. This collection also allows an institution to request a waiver of certain non-Federal cost-share requirements under the Federal Work-Study Program, Federal Supplemental Educational Opportunity Grant, and Student Support Services Program.

The collection is paired with a computational exercise that results in the simultaneous publication of an Eligibility Matrix, a listing of postsecondary institutions potentially eligible to apply for grants in Institutional Service. Criteria derived from applicable legislation and regulations are applied to enrollment and financial data from Department sources to determine the eligibility of each institution for each program. Only those institutions that either do not meet the financial criteria or do not appear in the Eligibility Matrix need to go through the application process.

The results of the application process are a determination of eligibility for grant application and waiver, and updated information on institutional eligibility which is added to the Eligibility Matrix.

This collection is being submitted under the Streamlined Clearance Process for Discretionary Grant Information Collections (1894-0001). Therefore, the 30-day public comment period notice will be the only public comment notice published for this information collection.

This CIC proceeding commenced on March 6, 2025, when MXP filed the CIC Notice, 2 followed by a supplement (First Supplement)  3 on March 21, 2025. The CIC Notice references Mexico Pacific Holdings, L.P. (MXP Holdings)—the entity that owns MXP and is now known as Mexico Pacific Holdings, LLC, as described below.

On May 7, 2025, DOE published notice of both the CIC Notice and the First Supplement in the Federal Register . 4 In response to this notice, DOE received a pleading jointly filed by Public Citizen, Inc., Natural Resources Defense Council (NRDC), and Sierra Club, in which these organizations protested the CIC Notice and Supplement and, as to NRDC and Sierra Club, moved to intervene in the CIC proceeding. 5

On May 30, 2025, in a “Second Supplement to CIC Notice Submitted March 5, 2025,”  6 MXP informed DOE that “multiple new investors are expected to be admitted to MXP Holdings.”  7

On August 8, 2025, MXP submitted a “Third Supplement to March 5, 2025 CIC Notice” (Third Supplement)  8 in which it notified DOE of the following changes, effective as of July 9, 2025:

(i) MXP Holdings converted its form of organization from a Delaware limited partnership (Mexico Pacific Holdings, L.P.) to a Delaware limited liability company named Mexico Pacific Holdings, LLC;

(ii) The then sole member and manager of MXP Holdings, Mexico Pacific Holdings GP, LLC (a Delaware limited liability company), with 70% economic interest in MXP Holdings, was renamed Windsor Cliff Sponsor, LLC (Windsor Cliff Sponsor); and

(iii) Three investors—two Florida limited liability companies and an individual—each acquired a 10% economic interest in MXP Holdings. 9

On October 29, 2025, DOE sent MXP a “Request for Information in Change of Control Proceeding” (Request for Information), 10 in which DOE asked MXP to provide additional information regarding the identity of the three minority investors referenced in the Third Supplement.

On November 24, 2025, MXP submitted the Fourth Supplement. 11 In the Fourth Supplement, MXP stated that it is responding to DOE's Request for Information and “provid[ing] a further supplement to MXP's March 5, 2025 CIC Notice.”  12 Specifically, MXP stated that, since its submission of its Third Supplement, “one of the three owners of a ten percent (10%) economic interest in MXP Holdings has assigned that minority interest to an Ontario limited partnership.”  13 Thus, following the completion of the assignment of a 10% economic interest in MXP Holdings, the three minority investors in MXP Holdings, each holding a 10% economic interest, are now:

• LDM Strategic Holdings, LLC, a Florida limited liability company;

• Avila Blue, LLC, a Florida limited liability company; and

• Sonvapor LP, an Ontario, Canada, limited partnership. 14

MXP stated that there are no affiliations among these entities beyond their minority interest in MXP Holdings.

Additional details can be found in MXP's filings available on the DOE website at https://www.energy.gov/fecm/mexico-pacific-limited-llc-mpl-fe-dkt-no-18-70-lng (Docket No. 18-70-LNG) and https://www.energy.gov/fecm/articles/mexico-pacific-limited-llc-mpl-fecm-docket-no-22-167-lng (Docket No. 22-167-LNG).

In accordance with DOE's CIC Procedures, 15 DOE will review the CIC Notice, as supplemented through the Fourth Supplement, showing that MXP Holdings' ownership is now: (i) Windsor Cliff Sponsor holding 70% of the membership interest in MXP Holdings, and (ii) the three minority investors identified above each holding a 10% economic interest in MXP Holdings (30% total). 16 MXP Holdings, in turn, continues to own 100% of MXP, the DOE authorization holder. 17

Consistent with the CIC Procedures, this notice addresses MXP's existing authorization to export liquefied natural gas (LNG) to countries with which the United States has not entered into a free trade agreement (FTA) requiring national treatment for trade in natural gas and with which trade is not prohibited by United States law or policy (non-FTA countries), granted in DOE/FE Order No. 4312, as amended. 18 If no interested person protests the change in control and DOE takes no action on its own motion, the proposed change in control will be deemed granted 30 days after publication in the Federal Register . If one or more protests are submitted, DOE will review any motions to intervene, protests, and answers, and will issue a determination as to whether the proposed change in control has been demonstrated to render the underlying authorizations inconsistent with the public interest.

Interested persons will be provided 15 days from the date of publication of this notice in the Federal Register to move to intervene, protest, and answer CIC Notice, as supplemented through the Fourth Supplement. 19 Protests, motions to intervene, notices of intervention, and written comments are invited in response to this notice only as to the change in control described in the CIC Notice, as supplemented through the Fourth Supplement. All protests, comments, motions to intervene, or notices of intervention must meet the requirements specified by DOE's regulations in 10 CFR part 590, including the service requirements.

Filings may be submitted using one of the following methods:

(1) Submitting the filing electronically at fergas@hq.doe.gov;

(2) Mailing the filing to the Office of Regulation, Analysis, and Engagement at the address listed in the ADDRESSES section; or

(3) Hand delivering the filing to the Office of Regulation, Analysis, and Engagement at the address listed in the ADDRESSES section.

For administrative efficiency, DOE prefers filings to be filed electronically. All filings must include a reference to “Docket Nos. 18-70-LNG, et al.” or “Mexico Pacific Limited LLC Change in Control” in the title line. Filings must be submitted in English to be considered. 20

For electronic submissions: Please include all related documents and attachments ( e.g., exhibits) in the original email correspondence. Please do not include any active hyperlinks or password protection in any of the documents or attachments related to the filing. All electronic filings submitted to DOE must follow these guidelines to ensure that all documents are filed in a timely manner.

MXP's filings in this CIC proceeding, and any filed protests, motions to intervene, notices of intervention, and comments, will be available electronically on the DOE website at www.energy.gov/fecm/regulation.

Comments are invited on: (a) Whether the extended collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology.

This information collection request contains:

(1) OMB No.: 1910-5150;

(2) Information Collection Request Titled: ARRA Financing Program Annual Report;

(3) Type of Review: Extension;

(4) Purpose: DOE requires the collection of information for the revolving loan fund activities under grants awarded by the Energy Efficiency and Conservation Block Grant (EECBG) Program (funded by the American Recovery and Reinvestment Act of 2009). These annual reports are necessary to ensure continued compliance with the terms and conditions of the grant awards. The information collected is used by DOE program staff to track the recipients' activities, monitor their progress, and provide oversight for financing program expenditures and the repurposing of funds. The collected information also enables program staff to provide required or requested information on program activities to OMB, Congress, and the public. The respondents are 60 remaining active financing program entities;

(5) Annual Estimated Number of Respondents: 60;

(6) Annual Estimated Number of Total Responses: 60;

(7) Annual Estimated Number of Burden Hours: 180;

(8) Annual Estimated Reporting and Recordkeeping Cost Burden: $10,829.

Statutory Authority: DOE requires the collection of information for the Energy Efficiency and Conservation Block Grant (EECBG) Program, as set forth in the Energy Independence and Security Act of 2007 (EISA) (Pub. L. 110-140). This collection also meets OMB requirements for: (1) administration of American Recovery and Reinvestment Act of 2009 (ARRA or Recovery Act) (Pub. L. 111-5) Financing programs created as part of the EECBG formula and competitive grants; and (2) ARRA funds. The EECBG is authorized under the Energy Policy and Conservation Act (EPCA), as amended (42 U.S.C. 6321 et seq. and 17151 et seq. ).

This document of the Department of Energy was signed on December 9, 2025, by Eric Mahroum, Director, Office of State and Community Energy Programs, pursuant to delegated authority from the Acting Under Secretary of Energy. That document with the original signature and date is maintained by DOE. For administrative purposes only, and in compliance with requirements of the Office of the Federal Register, the undersigned DOE Federal Register Liaison Officer has been authorized to sign and submit the document in electronic format for publication, as an official document of the Department of Energy. This administrative process in no way alters the legal effect of this document upon publication in the Federal Register .

Signed in Washington, DC, on December 10, 2025.

This is a request for approval of a new collection. An agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.

Public comments were previously requested via the Federal Register on July 21, 2025, during a 60-day comment period (90 FR 34269). This notice allows for an additional 30 days for public comments. Supporting documents, which explain in detail the information that the EPA will be collecting, are available in the public docket for this ICR. The docket can be viewed online at www.regulations.gov or in person at the EPA Docket Center, WJC West, Room 3334, 1301 Constitution Ave. NW, Washington, DC. The telephone number for the Docket Center is 202-566-1744. For additional information about EPA's public docket, visit http://www.epa.gov/dockets.

Abstract: This is a new information collection activity that covers the paperwork burden for tracking the adoption of bilingual labeling of pesticide products. This ICR was developed as part of a requirement by the Pesticide Registration Improvement Act (PRIA). PRIA was enacted in 2004 and established a new system for registering pesticides including fees and guaranteed decision times, along with funding for farmworker protection activities. PRIA was reauthorized in 2007, 2012, 2019, and most recently on December 29, 2022 (PRIA 5). PRIA 5 amended the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) to require bilingual language translation for parts of the end-use pesticide product labels where translation is available in the EPA Spanish Translation Guide for Pesticide Labeling (or the Spanish Translation Guide). PRIA 5 requires that each registered pesticide product released for shipment include either the bilingual language translation for parts of the labeling contained in EPA's Spanish Translation Guide on the pesticide product container, or a link to such translation via scannable technology or other electronic methods readily accessible on the product label. Currently, bilingual labeling is implemented through a non-notification process (see PR Notice 98-10, entitled “Notifications, Non-Notifications and Minor Formulation Amendments” dated October 22, 1998). The non-notification process means that a product label may be updated with Spanish translations without notifying EPA (or EPA reviewing the label), if that is the only change being made to the label. Non-notification label changes are not systematically tracked by EPA. However, PRIA 5 also requires EPA to “develop and implement, and make publicly available, a plan for tracking the adoption of the bilingual labeling.” In response, EPA has developed a plan for tracking the adoption of the bilingual labeling. Public comments were originally requested on the draft plan during a 30-day comment period beginning on January 2, 2025 (90 FR 99 (FRL-12231-01)).

In addition to the ICR, EPA is publishing a final Pesticide Registration Notice (PRN), “ Establishment of a Plan to Track the Adoption of Bilingual Labeling on End Use Pesticide Product Labels”, which provides guidance and clarification to pesticide registrants and the public on how the Agency will track the adoption of bilingual labeling. While the requirements in the FIFRA and EPA regulations are binding on EPA and applicants, the PRN is not binding on EPA personnel, pesticide registrants and applicants, or the public. EPA may depart from the guidance where circumstances warrant and without prior notice. Likewise, pesticide applicants may assert that the guidance is not appropriate generally or not applicable to a specific pesticide product or registration decision. Registrants and applicants may propose alternatives to the guidance provided in any application to the Agency.

Form number: PFN-8500-31.

Respondents/affected entities: Entities potentially affected by this ICR include pesticide importers, pesticide manufacturers and government establishments responsible for agricultural pest and weed regulation.

Respondent's obligation to respond: Mandatory. 40 CFR 152.

Estimated number of potential respondents: 1,517.

Frequency of response: Annually.

Total estimated burden: 27,784 hours (per year). Burden is defined at 5 CFR 1320.3(b).

Total estimated costs: $3,648,965 (per year), which includes $0 annualized capital or operation & maintenance costs.

Changes in the estimates: This is a new collection.

OMB Control Number: 3060-0093.

Title: FCC Form 405—Application for Experimental Licensing Systems (ELS).

Form No.: FCC Form 405.

Type of Review: Extension of a currently approved collection.

Respondents: Individuals or households, business or other for-profit, not-for-profit institutions and state, local or tribal government.

Number of Respondents and Responses: 520 respondents and 520 responses.

Estimated Time per Response: 2.25 hours.

Frequency of Response: On occasion, and every two year reporting requirement.

Obligation to Respond: Required to obtain or retain benefits. Statutory authority for this information collection (IC) is contained in sections 4(i), 301, 302, 303(e), 303(f), and 303(r), of the Communications Act of 1934, as amended; 47 U.S.C. 154(i), 301, 302, 303(e), 303(f) and 303(r).

Total Annual Burden: 1,170 hours.

Total Annual Cost: $215,800.

Needs and Uses: This collection will be submitted as an extension after this 60 day comment period in order to obtain the full three year clearance from the OMB. Additionally, a title change to “FCC Form 405—Application for Experimental Licensing Systems (ELS)”.

FCC Form 405 is used by the Experimental Radio Service to apply for renewal of radio station licenses at the FCC. Section 307 of the Communications Act of 1934, as amended, limits the term of radio licenses to five years and requires that written applications be submitted for renewal. The regular license period for stations in the Experimental Radio Service is either two or five years.

The information submitted on FCC Form 405 is used by the Commission staff to evaluate the applicant/licensee's need for a license renewal. In performing this function, staff performs analysis of the renewal request as compared to the original license grant to ascertain if any changes are requested. If so, additional analysis is performed to determine if such changes met the requirements of the rules of the Experimental Radio Service for interference free operation. If needed, the collected information is used to coordinate such operation with other Commission bureaus or other Federal Agencies. All applications are also analyzed on their merits regarding whether they meet the general requirements for an Experimental license. These requirements are set out in 47 CFR part 5.

OMB Control Number: 3060-0760.

Title: 272 Sunset Order, WC Docket No. 06-120; Access Charge Reform, CC Docket No. 96-262, First Report and Order; Second Order on Reconsideration and Memorandum Opinion and Order; and Fifth Report and Order; Business Data Services Report and Order, WC Docket No. 16-143 et al.

Form Number: N/A.

Type of Review: Extension of a currently approved collection.

Respondents: Business or other for-profit.

Number of Respondents and Responses: 13 respondents; 66 responses.

Estimated Time per Response: 3-80 hours.

Frequency of Response: On-occasion reporting requirements and third-party disclosure requirement.

Obligation to Respond: Required to obtain or retain benefits. Statutory authority for this information collection is contained in 47 U.S.C. 1, 4(i)-(j) , 201-205 , and 303(r) of the Communications Act of 1934, as amended, 47 U.S.C. 151 , 154(i)-(j) , 201-205 , and 303(r) .

Total Annual Burden: 1,256 hours.

Total Annual Cost: $68,640.

Needs and Uses: On April 28, 2017, the Commission released the Business Data Services Order, WC Docket No. 16-143 et al., FCC 17-43, reforming the business data services/special access regulations for incumbent and competitive LECs. The Commission's reforms included replacing the application-based pricing flexibility rules with a new framework under which: (a) packet-based services, time division multiplexing (TDM) services with bandwidth greater than 45 mbps, and TDM transport services are not subject to ex ante pricing regulation; (b) a new standard is applied to determine the extent to which the Commission regulates price cap LECs' TDM end user channel terminations with bandwidth less than 45 mbps and certain other low bandwidth business data services. Under this standard, a price cap LEC is not subject to ex ante pricing regulation in the provision of these services in counties deemed competitive under the Commission's competitive market test or for which the price cap LEC previously obtained Phase II pricing flexibility; (c) the price cap LEC is subject to ex ante pricing regulation in other counties where it is the incumbent LEC, but in these counties the price cap LEC has downward pricing flexibility ( i.e., the equivalent of Phase I pricing flexibility under the prior rules); and (d) the Commission will update the competitive market test results every three years using data already collected in FCC Form 477.

Among other rules changes, the Business Data Services Report and Order repealed section 1.774, which set forth requirements for pricing flexibility applications, and added section 1.776, which limits the circumstances under which price cap LECs must file their business data services contracts as contract-based tariffs. The Commission also amended section 69.701 of its rules to specify that its pricing flexibility rules no longer apply to business data services.

9000-0095, Federal Acquisition Regulation Part 27 Requirements

This clearance covers the following information that offerors and contractors must submit in response to the requirements of the provisions and clauses in the Federal Acquisition Regulation (FAR) part 27, as codified in Chapter 1 of Title 48 of the Code of Federal Regulations:

FAR 52.227-2, Notice and Assistance Regarding Patent and Copyright Infringement. This clause requires contractors to notify the Government of any allegations of patent or copyright infringement arising during the performance of the contract. The clause requires contractors to furnish, when requested by the contracting officer, all evidence and information in the contractor's possession regarding such a claim or suit. This clause flows down to subcontracts that are expected to exceed the simplified acquisition threshold (SAT—currently $350,000).

FAR 52.227-6, Royalty Information. This provision requires offerors to report all royalties anticipated or paid in excess of $250 for the use of patented inventions by furnishing:

(1) Name and address of licensor.

(2) Date of license agreement.

(3) Patent numbers, patent application serial numbers, or other basis on which the royalty is payable.

(4) Brief description, including any part or model numbers of each contract item or component on which the royalty is payable.

(5) Percentage or dollar rate of royalty per unit.

(6) Unit price of contract item.

(7) Number of units.

(8) Total dollar amount of royalties.

Also, the contracting officer may ask the offeror to provide a copy of the current license agreement identifying claims to specific patents.

FAR 52.227-9, Refund of Royalties. This clause requires contractors to furnish to the contracting officer, before final payment under a contract, a statement of royalties paid or required to be paid in connection with performing the contract. The clause requires contractors to notify the contracting officer if the contractor is relieved, within three years after final payment under the contract, from payment of royalties included in the final contract price. This clause flows down to subcontracts in which the amount of royalties reported during negotiation of the subcontract exceeds $250.

FAR 52.227-11, Patent Rights—Ownership by the Contractor, or 52.227-13, Patent Rights—Ownership by the Government—Commerce Patent Regulations. These FAR clauses require a Government contractor to report all inventions made in the performance of work under a Government contract or subcontract for experimental, developmental, or research work to the contracting officer, submit a disclosure of the invention, and identify any publication, sale, or public use of the invention (52.227-11(c), 52.227-13(e)(1)). The contracting officer may modify 52.227-11(e) or otherwise supplement the clause to require contractors to submit periodic or interim and final reports listing subject inventions (27.303(b)(2)(i) and (ii)). The contracting officer may also require a contractor, under FAR 52.227-11, to: provide the filing date, serial number, title, patent number and issue date for any patent application filed on any subject invention in any country or, upon request, copies of any patent application so identified; and furnish the Government an irrevocable power to inspect and make copies of the patent application file when a Government employee is a co-inventor. (27.303(b)(2)(iv) and (v). In order to ensure that subject inventions are reported, the contractor is required to establish and maintain effective procedures for identifying and disclosing subject inventions (52.227-11, Alternate IV; 52.227-13(e)(1)). In addition, the contractor must require its employees, by written agreements, to disclose subject inventions (52.227-11(e)(2); 52.227-13(e)(4)). The contractor also has an obligation to utilize the subject invention, and agree to report, upon request, the utilization or efforts to utilize the subject invention (27.302(e); 52.227-11(f)).

FAR 52.227-14, Rights in Data-General. This clause enables the contractor to protect qualifying limited rights data and restricted computer software by withholding the data from the Government and instead delivering form, fit, and function data. For unauthorized marking of data, the contractor may provide written justification to substantiate the propriety of the markings for the contracting officer to consider whether or not the markings are to be canceled or ignored. For omitted or incorrect markings of data that has not been disclosed without restriction outside the Government, the contractor may request, within 6 months (or a longer time approved by the contracting officer) after delivery of the data, permission to have authorized notices placed on the data at the contractor's expense. Contractors shall obtain from their subcontractors all data and rights necessary to fulfill the contractor's obligations to the Government under the contract. If a subcontractor refuses to accept terms affording the Government those rights, the contractor shall notify the contracting officer of the refusal.

FAR 52.227-15, Representation of Limited Rights Data and Restricted Computer Software. This provision requires an offeror to represent that it has reviewed the requirements for the delivery of technical data or computer software and state, in response to a solicitation, whether data proposed for fulfilling the data delivery requirements qualifies as limited rights data or restricted computer software. If the Government does not receive unlimited rights, the offeror must provide a list of the data that qualify as limited rights data or restricted computer software. The offeror would identify any proprietary data it would use during contract performance, in order that the contracting officer might ascertain if such proprietary data should be delivered.

FAR 52.227-16, Additional Data Requirements. This clause requires contractors to keep, for possible delivery to the Government, any data, in addition to data already required to be delivered under the contract, first produced or specifically used in performance of the contract for a period of three years from the final acceptance of all items delivered under the contract. The data delivered under this clause may be in the form of computations, preliminary data, records of experiments, etc. For any data to be delivered under this clause, the Government will pay the contractor for converting the data into a specific form, and for reproducing and delivering the data. The purpose of such recordkeeping requirements is to ensure that, if all data requirements are not known prior to contract award, the Government can fully evaluate the research in order to ascertain future activities and to insure that the research was completed and fully reported, as well as to give the public an opportunity to assess the research results and secure any additional information.

FAR 52.227-17, Rights in Data-Special Works. This clause is included in solicitations and contracts primarily for production or compilation of data. It is used in rare and exceptional circumstances to permit the Government to limit the contractor's rights in data by preventing the release, distribution, and publication of any data first produced in the performance of the contract. This clause may also be limited to particular items and not the entire contract. This clause requires contractors to assign (with or without registration), or obtain the assignment of, the copyright to the Government or its designated assignee.

FAR 52.227-18, Rights in Data-Existing Works. This clause is used when the Government is acquiring existing audiovisual or similar works, such as books, without modification. This clause requires contractors to obtain a license for the Government to reproduce, prepare derivative works, and perform and display publicly the materials.

FAR 52.227-19, Commercial Computer Software License. This clause requires contractors to affix a notice on any commercial software delivered under the contract that provides notice that the Government's rights regarding the data are set forth in the contract.

FAR 52.227-20, Rights in Data-SBIR Program. This clause authorizes contractors under Small Business Innovation Research (SBIR) contracts to affix a notice to SBIR data delivered under the contract to limit the Government's rights to disclose data first produced under the contract. For omitted or incorrect markings of data that has not been disclosed without restriction outside the Government, the contractor may request, within 6 months (or a longer time approved by the contracting officer) after delivery of the data, permission to have authorized notices placed on the data at the contractor's expense. Contractors shall obtain from their subcontractors all data and rights necessary to fulfill the contractor's obligations to the Government under the contract. If a subcontractor refuses to accept terms affording the Government those rights, the contractor shall notify the contracting officer of the refusal.

FAR 52.227-21, Technical Data Declaration, Revision, and Withholding of Payment-Major Systems. This clause requires major systems contractors to certify that the data delivered under the contract is complete, accurate, and compliant with the requirements of the contract.

FAR 52.227-23, Rights to Proposal Data (Technical). This clause allows the Government to identify pages of a proposal that would not be subject to unlimited rights in the technical data.

The information collected is used to protect the Government's rights and interests.

Respondents/Recordkeepers: 830.

Total Annual Responses: 14,848.

Total Burden Hours: 55,600. (54,673 reporting hours + 927 recordkeeping hours).

Obtaining Copies: Requesters may obtain a copy of the information collection documents from the GSA Regulatory Secretariat Division by calling 202-501-4755 or emailing GSARegSec@gsa.gov. Please cite OMB Control No. 9000-0095, Federal Acquisition Regulation Part 27 Requirements.

FDA is requesting that public stakeholders—including patient and consumer advocacy groups—notify the Agency of their intent to participate in periodic stakeholder consultation meetings on the reauthorization of BsUFA. BsUFA authorizes FDA to collect user fees from the regulated industry to support the process for the review of biosimilar biological products. The authorization for the current program (BsUFA III) expires in September 2027. Without new legislation, FDA will no longer be able to collect user fees for future fiscal years.

Section 744I(f)(1) of the FD&C Act (21 U.S.C. 379j-53(f)(1)) requires that FDA consult with a range of stakeholders, including representatives from patient and consumer advocacy groups, in developing recommendations for the next BsUFA program. FDA will initiate the reauthorization process by holding a public meeting on December 3, 2025, where stakeholders and other members of the public will be given an opportunity to present their views on the reauthorization (90 FR 52967, November 24, 2025). Section 744I(f)(3) of the FD&C Act (21 U.S.C. 379j-53(f)(3)) further requires that FDA continue meeting with representatives from patient and consumer advocacy groups at least once every month during negotiations with the regulated industry to continue discussions of these stakeholders' views on the reauthorization. It is anticipated that these monthly stakeholder consultation meetings will commence in April 2026.

FDA is issuing this Federal Register notice to request that representatives from patient and consumer advocacy groups notify FDA of their intent to participate in the periodic stakeholder consultation meetings on BsUFA reauthorization. FDA believes that consistent stakeholder representation at these meetings will be important to ensure progress in these discussions. If you wish to participate in these stakeholder consultation meetings, please designate one or more representatives from your organization who will commit to attending these meetings and preparing for the discussions. Stakeholders who identify themselves through this notice will be included in all patient and consumer advocacy group stakeholder consultation discussions while FDA negotiates with the regulated industry. If a representative from a patient or consumer advocacy group decides to participate in these monthly meetings at a later time, that stakeholder may join the remaining monthly patient and consumer advocacy group stakeholder consultation meetings after notifying FDA of this intention (see ADDRESSES ). These stakeholder discussions will satisfy the consultation requirement in section 744I(f)(3) of the FD&C Act.

If you intend to participate in these continued periodic stakeholder consultation meetings regarding BsUFA reauthorization, please provide notification by email to BSUFAReauthorization@fda.hhs.gov by January 30, 2026. Your email should contain complete contact information, including name, title, affiliation, address, email address, phone number, and notice of any special accommodations required because of disability. Stakeholders will receive confirmation and additional information about the first meeting after FDA receives this notification. Information concerning BsUFA, including the text of the law, the BsUFA III Commitment Letter, key Federal Register documents, BsUFA-related guidances, performance reports, and financial reports may be found on the FDA website at https://www.fda.gov/industry/fda-user-fee-programs/biosimilar-user-fee-amendments.

The applicants listed in table 1 have informed FDA that these drug products are no longer marketed and have requested that FDA withdraw approval of the applications under the process in § 314.150(c) (21 CFR 314.150(c)). The applicants have also, by their requests, waived their opportunity for a hearing. Withdrawal of approval of an application or abbreviated application under § 314.150(c) is without prejudice to refiling.

Therefore, approval of the applications listed in table 1, and all amendments and supplements thereto, are hereby withdrawn as of January 12, 2026. Approval of each entire application is withdrawn, including any strengths and dosage forms inadvertently missing from table 1. Introduction or delivery for introduction into interstate commerce of products listed in table 1 without an approved new drug application or ANDA violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(a) and 331(d)). Drug products that are listed in table 1 that are in inventory on January 12, 2026 may continue to be dispensed until the inventories have been depleted or the drug products have reached their expiration dates or otherwise become violative, whichever occurs first.

FDA is issuing proposed order OTC000039 to amend OTC Monograph M020 to add bemotrizinol for use as a sunscreen active ingredient at concentrations up to 6 percent. FDA is issuing the proposed order pursuant to section 505G(b)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 355h(b)(1)).

OTC Monograph M020 describes the conditions under which OTC sunscreen drug products are GRASE under section 201(p)(1) of the FD&C Act (21 U.S.C. 321(p)(1)). OTC Monograph M020 is currently set forth in Final Administrative Order OTC000006, as deemed by sections 505G(b)(8) and 505G(k)(2)(B) of the FD&C Act, and was effective upon enactment of the Coronavirus Aid, Relief, and Economic Security Act (Pub. L. 116-136) on March 27, 2020. The conditions described in OTC Monograph M020 may be amended, revoked, or otherwise modified in accordance with the procedures of section 505G(b) of the FD&C Act.

On September 23, 2024, DSM Nutritional Products LLC submitted a Tier 1 OMOR requesting FDA issue an administrative order finding that a sunscreen drug product containing bemotrizinol as an active ingredient is GRASE under the conditions described in OTC Monograph M020. The proposed order, if finalized, will amend the conditions described in OTC Monograph M020, currently set forth in the Final Administrative Order OTC000006, to add bemotrizinol at concentrations up to 6 percent as a sunscreen active ingredient. FDA proposes to determine that a sunscreen drug product containing bemotrizinol as an active ingredient is GRASE if it meets the conditions described in OTC Monograph M020 as amended by this proposed order. Among the conditions for drug products containing bemotrizinol as a sunscreen active ingredient specified by this proposed order, if finalized, are conditions that address the concentration of bemotrizinol in the sunscreen drug product, permitted combinations of bemotrizinol with other sunscreen active ingredients and with skin protectant active ingredients, and permitted dosage forms. Specific to dosage forms, the proposed order, if finalized, would permit the following dosage forms: oil, lotion, cream, gel, butter, paste, ointment, stick, and spray, provided that the product in spray dosage form is manufactured and packaged with no propellant or is manufactured and packaged in a spray delivery system where all propellant is isolated from the drug product formulation within the container closure system, and there is no contact between the propellant and the drug product formulation.

The proposed order can be viewed in the OTC Monographs@FDA portal at https://www.accessdata.fda.gov/scripts/cder/omuf/. The proposed order contains instructions for commenting on the proposed order. Comments to the proposed order must be submitted electronically to the Federal eRulemaking Portal at https://www.regulations.gov.

OTC Monographs@FDA provides a resource for the public to view administrative orders (proposed, final, and interim final orders) for OTC Monograph Drugs and view OTC Monographs. In the future, OTC Monographs@FDA will facilitate the public's ability to submit, search, and view comments and data for proposed and interim final orders.

The proposed order OTC000039 is issued under section 505G(b)(1) of the FD&C Act. Under section 505G(o) of the FD&C Act, the Paperwork Reduction Act of 1995 (Chapter 35 of title 44, United States Code) does not apply to collections of information made under section 505G of the FD&C Act. Therefore, clearance by the Office of Management and Budget under the Paperwork Reduction Act of 1995 is not required for collections of information, if any, in a final order issued under section 505G that results from this proposed order.

Section 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 355(j)) allows the submission of an ANDA to market a generic version of a previously approved drug product. To obtain approval, the ANDA applicant must show, among other things, that the generic drug product: (1) has the same active ingredient(s), dosage form, route of administration, strength, conditions of use, and (with certain exceptions) labeling as the listed drug, which is a version of the drug that was previously approved, and (2) is bioequivalent to the listed drug. ANDA applicants do not have to repeat the extensive clinical testing otherwise necessary to gain approval of a new drug application (NDA).

Section 505(j)(7) of the FD&C Act requires FDA to publish a list of all approved drugs. FDA publishes this list as part of the “Approved Drug Products With Therapeutic Equivalence Evaluations,” which is known generally as the “Orange Book.” Under FDA regulations, drugs are removed from the list if the Agency withdraws or suspends approval of the drug's NDA or ANDA for reasons of safety or effectiveness or if FDA determines that the listed drug was withdrawn from sale for reasons of safety or effectiveness (21 CFR 314.162).

A person may petition the Agency to determine, or the Agency may determine on its own initiative, whether a listed drug was withdrawn from sale for reasons of safety or effectiveness. This determination may be made at any time after the drug has been withdrawn from sale, but must be made prior to approving an ANDA that refers to the listed drug (§ 314.161 (21 CFR 314.161)). FDA may not approve an ANDA that does not refer to a listed drug.

ZANTAC (ranitidine HCl) injection, EQ 25 mg base/mL, is the subject of NDA 019090, held by Pharmaceutical Associates, Inc. (PAI) Pharma, and initially approved on October 19, 1984. ZANTAC (ranitidine HCl) injection, EQ 25 mg base/mL is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable duodenal ulcers, or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication.

On March 31, 2020, FDA requested that all manufacturers voluntarily withdraw their ranitidine products from the market because accumulated data showed levels of N-Nitrosodimethylamine (NDMA) above the acceptable daily intake limit in many ranitidine-containing products. 1 This request applied to all ranitidine applicants, including the applicant for ZANTAC (ranitidine HCl) injection, EQ 25 mg base/mL, NDA 019090. ZANTAC (ranitidine HCl) injection, EQ 25 mg base/mL, NDA 019090, was withdrawn from sale prior to March 31, 2020. ZANTAC (ranitidine HCl) injection, EQ 25 mg base/mL, is currently listed in the “Discontinued Drug Product List” section of the Orange Book.

After reviewing Agency records and based on the information we have at this time, FDA has determined under § 314.161 that ZANTAC (ranitidine HCl) injection, EQ 25 mg base/mL, has not been withdrawn for reasons of safety or effectiveness to the extent that the drug can be manufactured or formulated in a manner that satisfies any applicable acceptable intake limit for nitrosamine impurities.

Accordingly, the Agency will continue to list ZANTAC (ranitidine HCl) injection, EQ 25 mg base/mL, in the “Discontinued Drug Product List” section of the Orange Book. The “Discontinued Drug Product List” delineates, among other items, drug products that have been discontinued from marketing for reasons other than safety or effectiveness. FDA will not begin procedures to withdraw approval of approved ANDAs that refer to this drug product. Additional ANDAs for this drug product may be approved by the Agency as long as they meet all other legal and regulatory requirements for the approval of ANDAs, including satisfying any applicable acceptable intake limit for nitrosamine impurities. If FDA determines that labeling for this drug product should be revised to meet current standards, the Agency will advise ANDA applicants to submit such labeling.

Section 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 355(j)) allows the submission of an ANDA to market a generic version of a previously approved drug product. To obtain approval, the ANDA applicant must show, among other things, that the generic drug product: (1) has the same active ingredient(s), dosage form, route of administration, strength, conditions of use, and (with certain exceptions) labeling as the listed drug, which is a version of the drug that was previously approved, and (2) is bioequivalent to the listed drug. ANDA applicants do not have to repeat the extensive clinical testing otherwise necessary to gain approval of a new drug application (NDA).

Section 505(j)(7) of the FD&C Act requires FDA to publish a list of all approved drugs. FDA publishes this list as part of the “Approved Drug Products With Therapeutic Equivalence Evaluations,” which is known generally as the “Orange Book.” Under FDA regulations, a drug is removed from the list if the Agency withdraws or suspends approval of the drug's NDA or ANDA for reasons of safety or effectiveness or if FDA determines that the listed drug was withdrawn from sale for reasons of safety or effectiveness (21 CFR 314.162).

A person may petition the Agency to determine, or the Agency may determine on its own initiative, whether a listed drug was withdrawn from sale for reasons of safety or effectiveness. This determination may be made at any time after the drug has been withdrawn from sale, but must be made prior to approving an ANDA that refers to the listed drug (§ 314.161 (21 CFR 314.161)). FDA may not approve an ANDA that does not refer to a listed drug.

BACTROBAN (mupirocin) nasal ointment, 2%, is the subject of NDA 050703, held by SmithKline Beecham (Cork) Ltd., Ireland/GlaxoSmithKline (GSK), and was initially approved on September 18, 1995. BACTROBAN nasal ointment, 2%, is indicated for the eradication of nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) in adult and pediatric patients (aged 12 years and older) and healthcare workers as part of a comprehensive infection control program to reduce the risk of infection among patients at high risk of MRSA infection during institutional outbreaks of infections with this microorganism.

In a correspondence dated February 9, 2018, GSK notified FDA that BACTROBAN (mupirocin) nasal ointment, 2%, was being discontinued, and FDA moved the drug product to the “Discontinued Drug Product List” section of the Orange Book. In a letter dated January 5, 2022, GSK requested withdrawal of NDA 050703 for BACTROBAN (mupirocin) nasal ointment, 2%, under § 314.150(c) (21 CFR 314.150(c)). In the Federal Register of August 4, 2025, FDA announced that it was withdrawing approval of NDA 050703 upon request of GSK under § 314.150(c), effective September 3, 2025.

E4 Consulting submitted a citizen petition dated June 24, 2020 (Docket No. FDA-2020-P-1617), under 21 CFR 10.30, requesting that the Agency determine whether BACTROBAN (mupirocin) nasal ointment, 2%, was withdrawn from sale for reasons of safety or effectiveness.

After considering the citizen petition and reviewing Agency records and based on the information we have at this time, FDA has determined under § 314.161 that BACTROBAN (mupirocin) nasal ointment, 2%, was not withdrawn for reasons of safety or effectiveness. The petitioner has identified no data or other information suggesting that BACTROBAN (mupirocin) nasal ointment, 2%, was withdrawn for reasons of safety or effectiveness. We have carefully reviewed our files for records concerning the withdrawal of BACTROBAN (mupirocin) nasal ointment, 2%, from sale. We have also independently evaluated relevant literature and data for possible postmarketing adverse events. We have found no information that would indicate that this drug product was withdrawn from sale for reasons of safety or effectiveness.

Accordingly, the Agency will continue to list BACTROBAN (mupirocin) nasal ointment, 2%, in the “Discontinued Drug Product List” section of the Orange Book. The “Discontinued Drug Product List” delineates, among other items, drug products that have been discontinued from marketing for reasons other than safety or effectiveness. ANDAs that refer to BACTROBAN (mupirocin) nasal ointment, 2%, may be approved by the Agency as long as they meet all other legal and regulatory requirements for the approval of ANDAs. If FDA determines that labeling for this drug product should be revised to meet current standards, the Agency will advise ANDA applicants to submit such labeling.

Section 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 355(j)) allows the submission of an ANDA to market a generic version of a previously approved drug product. To obtain approval, the ANDA applicant must show, among other things, that the generic drug product: (1) has the same active ingredient(s), dosage form, route of administration, strength, conditions of use, and (with certain exceptions) labeling as the listed drug, which is a version of the drug that was previously approved, and (2) is bioequivalent to the listed drug. ANDA applicants do not have to repeat the extensive clinical testing otherwise necessary to gain approval of a new drug application (NDA).

Section 505(j)(7) of the FD&C Act requires FDA to publish a list of all approved drugs. FDA publishes this list as part of the “Approved Drug Products With Therapeutic Equivalence Evaluations,” which is known generally as the “Orange Book.” Under FDA regulations, drugs are removed from the list if the Agency withdraws or suspends approval of the drug's NDA or ANDA for reasons of safety or effectiveness or if FDA determines that the listed drug was withdrawn from sale for reasons of safety or effectiveness (21 CFR 314.162).

A person may petition the Agency to determine, or the Agency may determine on its own initiative, whether a listed drug was withdrawn from sale for reasons of safety or effectiveness. This determination may be made at any time after the drug has been withdrawn from sale, but must be made prior to approving an ANDA that refers to the listed drug (§ 314.161 (21 CFR 314.161)). FDA may not approve an ANDA that does not refer to a listed drug.

LUNELLE (estradiol cypionate and medroxyprogesterone acetate) injectable, 5 mg/0.5 mL estradiol cypionate and 25 mg/0.5 mL medroxyprogesterone acetate, is the subject of NDA 020874, held by Pharmacia and Upjohn Co., and initially approved on October 5, 2000. LUNELLE is indicated for the prevention of pregnancy.

In a letter dated June 24, 2003, Pharmacia and Upjohn Co. requested withdrawal of NDA 020874 for LUNELLE (estradiol cypionate and medroxyprogesterone acetate) injectable, 5 mg/0.5 mL estradiol cypionate and 25 mg/0.5 mL medroxyprogesterone acetate. In the Federal Register of May 5, 2004 (69 FR 25124), FDA announced that it was withdrawing approval of NDA 020874, effective June 4, 2004.

Sarah A. Norring, Ph.D. submitted a citizen petition dated June 20, 2024 (Docket No. FDA-2024-P-2952), under 21 CFR 10.30, requesting that the Agency determine whether LUNELLE (estradiol cypionate and medroxyprogesterone acetate) injectable, 5 mg/0.5 mL estradiol cypionate and 25 mg/0.5 mL medroxyprogesterone acetate, was withdrawn from sale for reasons of safety or effectiveness.

After considering the citizen petition and reviewing Agency records and based on the information we have at this time, FDA has determined under § 314.161 that LUNELLE (estradiol cypionate and medroxyprogesterone acetate) injectable, 5 mg/0.5 mL estradiol cypionate and 25 mg/0.5 mL medroxyprogesterone acetate, was not withdrawn for reasons of safety or effectiveness. The petitioner provided information about a voluntary recall of prefilled syringes of LUNELLE in October 2002 due to potential manufacturing issues at a particular facility. We have carefully reviewed our files for records concerning the withdrawal of LUNELLE (estradiol cypionate and medroxyprogesterone acetate) injectable, 5 mg/0.5 mL estradiol cypionate and 25 mg/0.5 mL medroxyprogesterone acetate, from sale. We have also independently evaluated relevant literature and data for possible postmarketing adverse events. We have reviewed the available evidence and determined that this drug product was not withdrawn from sale for reasons of safety or effectiveness.

Accordingly, the Agency will continue to list LUNELLE (estradiol cypionate and medroxyprogesterone acetate) injectable, 5 mg/0.5 mL estradiol cypionate and 25 mg/0.5 mL medroxyprogesterone acetate, in the “Discontinued Drug Product List” section of the Orange Book. The “Discontinued Drug Product List” delineates, among other items, drug products that have been discontinued from marketing for reasons other than safety or effectiveness. ANDAs that refer to LUNELLE (estradiol cypionate and medroxyprogesterone acetate) injectable, 5 mg/0.5 mL estradiol cypionate and 25 mg/0.5 mL medroxyprogesterone acetate, may be approved by the Agency as long as they meet all other legal and regulatory requirements for the approval of ANDAs. If FDA determines that labeling for this drug product should be revised to meet current standards, the Agency will advise ANDA applicants to submit such labeling.